Related Experiment Video
Updated: Aug 6, 2026
06:29
Accurate and Simple Measurement of the Pro-inflammatory Cytokine IL-1β using a Whole Blood Stimulation Assay
Published on: March 1, 2011
Interleukin 1 enhances arterial thrombogenicity in vitro
1Department of Medicine, Minneapolis VA Medical Center, MN.
Thrombosis Research
|November 15, 1989
Summary
Interleukin 1 increases platelet aggregate formation on de-endothelialized arteries, enhancing vascular thrombogenicity. This effect is mediated by non-endothelial vascular cells, independent of prostacyclin or thromboxane production.
Area of Science:
- Vascular Biology
- Hematology
- Immunology
Background:
- Vascular thrombogenicity, the tendency of blood vessels to form clots, is a critical factor in cardiovascular diseases.
- Interleukin 1 (IL-1) is a pro-inflammatory cytokine implicated in various pathological processes, including thrombosis.
- The role of IL-1 in modulating vascular thrombogenicity, particularly in the absence of intact endothelium, requires further elucidation.
Purpose of the Study:
- To investigate the effect of Interleukin 1 on platelet adhesion and aggregate formation on de-endothelialized human umbilical arteries in vitro.
- To determine if Interleukin 1 alters vascular thrombogenicity through changes in prostacyclin and thromboxane production.
Main Methods:
- Utilized an annular perfusion chamber model to assess platelet adhesion.
- De-endothelialized human umbilical artery segments were cultured with or without Interleukin 1.
- Artery segments were perfused with human blood, fixed, and analyzed using morphometric analysis for platelet aggregation.
- Quantified prostacyclin and thromboxane release from vascular cells.
Main Results:
- Exposure to Interleukin 1 (100 Units/ml for 2-20 hours) significantly increased the number and size of platelet aggregates on de-endothelialized artery segments compared to controls.
- A monolayer of platelets was observed on control segments, while significant platelet aggregation occurred on IL-1 treated segments.
- No significant alteration in the quantity or ratio of prostacyclin and thromboxane released by vascular cells was observed following Interleukin 1 exposure.
Conclusions:
- Interleukin 1 enhances arterial thrombogenicity in de-endothelialized vessels by promoting platelet aggregate formation.
- The pro-thrombotic effect of Interleukin 1 on vascular cells is not mediated by alterations in prostacyclin or thromboxane production.
- Non-endothelial vascular cells play a significant role in mediating Interleukin 1-induced changes in vascular thrombogenicity.
Related Concept Videos
01:17Intracellular Signaling Affects Focal Adhesions
Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
Some...
01:25Acute Inflammation III: Local and Systemic Effects
Acute inflammation produces a coordinated set of local and systemic changes that limit injury, eliminate pathogens, and initiate repair. These responses arise within minutes of infection, trauma, or chemical insult and are driven by vascular alterations and leukocyte-derived mediators. When the stimulus resolves, the reaction typically abates within days.Local EffectsAt the site of injury, arteriolar vasodilation increases blood flow, resulting in redness and warmth. Simultaneously, increased...